| Literature DB >> 34466480 |
Majid Rezaei-Tavirani1, Vahid Mansouri2, Mostafa Rezaei Tavirani2, Mohammad Rostami-Nejad3, Davood Bashash2, Mona Zamanian Azodi2.
Abstract
BACKGROUND: Severe burns injury can affect several vital systems in the body and can cause inflammation in organs such as the heart, liver, and kidney. Many inflammatory mediators and regulatory hormones related to burn injuries are recognized. In this study, the genes related to burn injury interacted via network analysis, and the central nodes were enriched through gene ontology (GO).Entities:
Keywords: Biochemical Pathway; Biomarker; Burn; Gene; Protein-Protein Interaction Network
Year: 2019 PMID: 34466480 PMCID: PMC8344118 DOI: 10.31661/gmj.v8i0.1257
Source DB: PubMed Journal: Galen Med J ISSN: 2322-2379
Figure 1
Figure 2Hub-nodes of Burn PPI Network are shown. D and BC Refer to Degree and Betweenness Centrality Respectively
|
|
|
|
|
|
|
| ALB | albumin | 502 | 0.12 |
|
| INS | insulin | 407 | 0.06 |
|
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 359 | 0.03 |
|
| TP53 | tumor protein p53 | 350 | 0.04 |
|
| IL6 | interleukin 6 (interferon, beta 2) | 336 | 0.02 |
|
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 320 | 0.03 |
|
| EGF | epidermal growth factor | 294 | 0.01 |
|
| TNF | tumor necrosis factor | 293 | 0.02 |
|
| VEGFA | vascular endothelial growth factor A | 289 | 0.01 |
|
| JUN | jun proto-oncogene | 279 | 0.02 |
|
| EGFR | epidermal growth factor receptor | 262 | 0.02 |
|
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | 262 | 0.01 |
|
| IL8 | interleukin 8 | 258 | 0.01 |
|
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 241 | 0.01 |
|
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 238 | 0.01 |
|
| MAPK1 | mitogen-activated protein kinase 1 | 233 | 0.01 |
|
| MAPK3 | mitogen-activated protein kinase 3 | 231 | 0.01 |
|
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 223 | 0.01 |
|
| BCL2 | B-cell CLL/lymphoma 2 | 219 | 0.01 |
|
| F2 | coagulation factor II (thrombin) | 215 | 0.01 |
|
| IL2 | interleukin 2 | 213 | 0.01 |
|
| IL4 | interleukin 4 | 207 | 0.01 |
|
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 201 | 0.01 |
|
| DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial | 198 | 0.01 |
|
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 198 | 0.02 |
|
| HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 198 | 0.01 |
|
| ESR1 | estrogen receptor 1 | 196 | 0.01 |
|
| CALM2 | calmodulin 2 (phosphorylase kinase, delta) | 195 | 0.01 |
|
| CALM3 | calmodulin 3 (phosphorylase kinase, delta) | 190 | 0.01 |
|
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 185 | 0.01 |
|
| LEP | leptin | 179 | 0.01 |
|
| APP | amyloid beta (A4) precursor protein | 178 | 0.01 |
|
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 176 | 0.01 |
|
| CCND1 | cyclin D1 | 169 | 0.01 |
|
| CYCS | cytochrome c, somatic | 168 | 0.01 |
Classified hub-nodes of burn PPI Network are presented. The name of group is determined based on roles of genes in body. For example the genes of group-3 are known as cancer marker as it is mentioned in the related references.
|
|
|
|
|
|
| ALB | albumin | |
|
| INS, CYCS, DECR1, GAPDH, LEP | Metabolic and energy expenditure genes | (13-17) |
|
| TP53, AKT1, TNF, JUN, FOS, MYC, HRAS, PIK3CA, CCND1, ITGA2 | Cancer markers | (18-20) |
|
| IL2, IL4, IL6, IL8, EGF, EGFR, VEGFA, IGF, STAT3 | Interleukins and growth factors | (21, 22) |
|
| MAPK1, MAPK3, CALM1,CALM2, CALM3, BCL2, CASP3 | Cell function regulators | (23-26) |
|
| APP, F2, ESR1 | Other genes |
Figure 3Classified related pathways of burn PPI network are shown Group name was determined based on the common features pathways. For example the first group are affected by immunological events in body so are marked as Immunological related pathways.
|
|
|
|
| 1 | Inflammatory bowel disease (IBD), IL-17 signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation | Immunological related pathways |
| 2 | Type II diabetes mellitus | Metabolic related pathway |
| 3 | Glioma, Colorectal cancer, Melanoma | Cancer related pathways |
| 4 | Kaposi,s sarcoma-associated herpesvirus infection, Chagas disease (American trypanosomiasis), Hepatitis B, Pertussis (bacteri) | Infection related pathways |
| 5 | Neurotropin signaling pathway | Nervous system related pathway |
| 6 | Prolactin signaling pathway | Reproduction and lactation related pathway |